Picton Mahoney Asset Management’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Picton Mahoney Asset Management’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-225,000	Closed	-$5.42M	–	577
2023 Q1	$5.42M	Buy	+225,000	New	+$2.82M	0.24%	134

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Picton Mahoney Asset Management's PRVB Position: Q2 2023 in Review

Picton Mahoney Asset Management sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 225,000 shares — an estimated $5.42M sold.

Picton Mahoney Asset Management first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $5.42M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Picton Mahoney Asset Management reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Picton Mahoney Asset Management sold 225,000 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $5.42M.
Picton Mahoney Asset Management first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Picton Mahoney Asset Management's Provention Bio, Inc. Common Stock position peaked at $5.42M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Picton Mahoney Asset Management's 13F filing for Q2 2023, filed 3 Aug 2023.